1. Home
  2. GHG vs COYA Comparison

GHG vs COYA Comparison

Compare GHG & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.08

Market Cap

116.0M

ML Signal

HOLD

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

HOLD

Current Price

$4.84

Market Cap

110.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
COYA
Founded
2004
2020
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
110.0M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
GHG
COYA
Price
$1.08
$4.84
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.80
AVG Volume (30 Days)
7.2K
125.9K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
4.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,945,753.00
Revenue This Year
$19.02
N/A
Revenue Next Year
$8.26
$763.10
P/E Ratio
$5.76
N/A
Revenue Growth
N/A
123.57
52 Week Low
$1.08
$3.71
52 Week High
$2.57
$7.75

Technical Indicators

Market Signals
Indicator
GHG
COYA
Relative Strength Index (RSI) 45.12 54.27
Support Level $1.10 $4.45
Resistance Level $1.16 $5.10
Average True Range (ATR) 0.02 0.21
MACD -0.00 0.06
Stochastic Oscillator 37.50 62.67

Price Performance

Historical Comparison
GHG
COYA

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Share on Social Networks: